A Current and Future Perspective on Adjuvant and Neoadjuvant Recirculating Chemohyperthermia as a Treatment for Intermediate-High Risk NMIBC

Nearly 75% of bladder cancer diagnoses are for non-muscle invasive bladder cancer (NMIBC), and more than half of these cases relapse after transurethral excision of the bladder tumour. Traditional methods for preventing recurrences include immunotherapy with bacillus Calmette-Guérin (BCG) and

Read More

Preliminary Screening Workers Exposed to 4,4’-Methylenebis(2-Chloroaniline) (MBOCA) for Bladder Cancer in Taiwan

At four MBOCA manufacturing plants in Taiwan, a software to track 4,4'-Methylenebis(2-chloroanilin) (MBOCA) levels in the workplace and test for bladder cancer was implemented. According to the findings of this report, there is a proven bladder carcinoma in MBOCA manufacturing

Read More

Mild Dehydration and Apparent Relationship with Bladder and Colorectal Cancers

Background: The significance of water consumption/dehydration in cancer has not been elucidated to this day. Objective: Review the importance of water in colorectal and bladder cancers. Methods: A critical review of the literature highlighted urinary tract infection and constipation with

Read More